Live tape
Top 8, mentions 7d6,968META1,793 mentions▲ +0.06GOOGL1,433 mentions▲ +0.03NVDA885 mentions▲ +0.09TSLA655 mentions▲ +0.05MSFT580 mentions▲ +0.06SPY571 mentions▲ +0.03AMZN554 mentions▲ +0.04AAPL497 mentions▲ +0.07

Equity · Real Estate

SBRA

NASDAQ

Sabra Health Care REIT, Inc.

$20.11 +0.55% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 17, 2026
Price · Chart
Our own end-of-day closes 11 sessions
$20.2 $19.4 2 Jul 17 Jul

The line runs $20.16 on 2 July through $20.11 on 17 July, on a scale from $19.4 to $20.2. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of SBRA over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 11 sessions over that window: $20.16 on 2 July 2026 through $20.11 on 17 July 2026.

Market cap $5.1B
P/E (TTM) 77.4
52-week range $17.24 – $21.21
Avg volume 962.7K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Jul 17, 2026

SBRA insider trades

SEC Form 4 · last 90 days · newest reported trade 8 Sep 2026
Open-market buys 0
Open-market sells 1
Net sold $4.17M
Non-trade filings 10
Date Insider Type Shares Value
08 Sep 2026 MATROS RICHARD K Chair, CEO and President Sell 200,000 $4.17M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
31 Aug 2026 Barbarosh Craig A. Director Award 791
31 Aug 2026 Costa Michael Lourenco Executive VP, CFO & Treasurer Award 4,158
31 Aug 2026 Cusack Catherine Director Award 791
31 Aug 2026 FLORES JESSICA Executive VP & CAO Award 382
31 Aug 2026 FOSTER MICHAEL J Director Award 791
31 Aug 2026 KATZMANN LYNNE S Director Award 791
31 Aug 2026 Kono Ann Director Award 791
31 Aug 2026 MATROS RICHARD K Chair, CEO and President Award 13,867
31 Aug 2026 Malehorn Jeffrey A. Director Award 791
31 Aug 2026 Smith Darrin Executive VP, CIO & Secretary Award 495

SBRA reported financials

SEC EDGAR XBRL

SBRA reported revenue of $356.9M for the fiscal year ended 31 Dec 2025. Net income over the same period was $155.6M.

Figure Reported Period
Revenue $356.9M 31 Dec 2025 fiscal year
Net income $155.6M 31 Dec 2025 fiscal year
Diluted EPS $0.64 31 Dec 2025 fiscal year
Total assets $5.5B 30 Jun 2026 at period end
Total equity $2.8B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

SBRA earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.10 $236M
31 Mar 2026 Q1 2026 $0.16 $222M
31 Dec 2025 FY 2025 $0.64 $775M
30 Sep 2025 Q3 2025 $0.09 $190M
30 Jun 2025 Q2 2025 $0.27 $189M
31 Mar 2025 Q1 2025 $0.17 $184M
31 Dec 2024 FY 2024 $0.54 $703M
30 Sep 2024 Q3 2024 $0.13 $178M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

SBRA institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a SBRA position for the quarter ended 30 Jun 2026 — a combined $157.9M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
AQR Capital Management Added +41.4% shares 1,998,848 $39.0M
Two Sigma Investments Held (±25%) −22.3% shares 1,947,826 $38.0M
Point72 Asset Management Added +99.0% shares 1,115,011 $21.8M
D. E. Shaw & Co. Held (±25%) −10.6% shares 833,693 $16.3M
Millennium Management Trimmed −52.9% shares 746,172 $14.6M
Tudor Investment Corp Added +1,070.4% shares 631,543 $12.3M
Citadel Advisors Held (±25%) −15.5% shares 530,392 $10.3M
Marshall Wace Added +25.5% shares 135,438 $2.6M
Man Group New position 103,321 $2.0M
Balyasny Asset Management Added +279.0% shares 53,074 $1.0M

Source: SEC EDGAR 13F filings

SBRA fails-to-deliver

SEC CNS data

On 11 Sep 2026, 181,086 shares of SBRA failed to deliver (about $3.8M).

Settlement date Shares failed Notional % of shares out
11 Sep 2026 181,086 $3.8M 0.071%
28 Aug 2026 43 $890 <0.001%
27 Aug 2026 26 $546 <0.001%
20 Aug 2026 3,794 $78K 0.001%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in SBRA

STOCK Act disclosures

The most recent congressional trade disclosed in SBRA is a sale by Daniel S. Goldman (house, NY), dated 10 Apr 2023.

Date Member Type Amount
10 Apr 2023 filed 19 May 2023 Daniel S. Goldman house · Democrat–NY Sale $1K–$15K
01 Mar 2023 filed 17 Apr 2023 Daniel S. Goldman house · Democrat–NY Purchase $1K–$15K
08 Nov 2022 filed 12 Dec 2022 Sara Jacobs house · Democrat–CA Sale $1K–$15K

Source: U.S. House of Representatives financial disclosures